Detalhe da pesquisa
1.
CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.
J Infect Dis
; 212(9): 1397-401, 2015 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25895986
2.
Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate.
Small
; 9(15): 2553-63, 2478, 2013 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-23447456
3.
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.
J Virol
; 86(2): 1119-28, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22090117
4.
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.
J Virol
; 86(12): 6416-26, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22491471
5.
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.
Antimicrob Agents Chemother
; 56(4): 1931-5, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22252820
6.
Antiretroviral therapy in the clinic.
J Virol
; 84(11): 5458-64, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20181709
7.
Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.
J Infect Dis
; 202(10): 1478-81, 2010 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20936980
8.
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
Clin Infect Dis
; 48(5): 642-9, 2009 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19191652
9.
Case records of the Massachusetts General Hospital. Case 6-2011. A 77-year-old man with dyspnea, weakness, and diaphoresis.
N Engl J Med
; 364(8): 759-67, 2011 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-21345106
10.
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.
J Virol
; 82(16): 8210-4, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18495779
11.
SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.
PLoS One
; 6(12): e28047, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22164225
12.
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.
J Acquir Immune Defic Syndr
; 55(4): 420-7, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20856130
13.
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.
PLoS One
; 4(5): e5683, 2009 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-19479085
14.
Human immunodeficiency virus and the postmenopausal woman: genital shedding may remain the same.
Menopause
; 19(2): 124-5, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22258542
15.
Chemokine antagonists as therapeutics: focus on HIV-1.
Annu Rev Med
; 58: 445-59, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-16958560
16.
The end of the association between XMRV, MLV-like viruses and chronic fatigue syndrome.
Virulence
; 2(6): 493-4, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22186762